Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 29, Issue 12, 2002, Pages 967-972

  Allan, D S ^a   Keeney, M ^a   Howson Jan, K ^a   Popma, J ^a   Weir, K ^a   Bhatia, M ^a   Sutherland, D R ^a   Chin Yee, I H ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Autologous; CD34; Engraftment; Transplantation; Viability

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DACTINOMYCIN; DYE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; STEM CELL FACTOR; CD34 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CELL LOSS; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; GERM CELL TUMOR; GRAFT FAILURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFUSION; LYMPHOCYTE COUNT; LYMPHOMA; MULTIPLE MYELOMA; NEUTROPHIL; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; RETREATMENT; RISK ASSESSMENT; STEM CELL; SURGICAL TECHNIQUE; THAWING; THROMBOCYTE FUNCTION; CELL COUNT; CELL SURVIVAL; CYTOLOGY; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; KINETICS; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; NEOPLASM; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDY; STANDARD;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; CELL COUNT; CELL SURVIVAL; CRYOPRESERVATION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; KINETICS; MIDDLE AGED; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES; SPECIMEN HANDLING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036330398     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703575     Document Type: Article

References (26)

1. The biology and clinical uses of blood stem cells
2. Defining a therapeutic dose of peripheral blood stem cells
3. Identification of a membrane glycoprotein associated with hematopoietic progenitor cells
4. The CD34 antigen: Structure, biology and potential clinical applications
5. Antigen CD34-positive marrow cells engraft lethally irradiated baboons
6. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma
7. Effect of peripheral blood progenitor cells mobilized by filgastrim (G-CSF) on platelet recovery after high dose chemotherapy
8. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte macrophage colony stimulating factor for hematologic support after high dose intensification for breast cancer
9. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor
10. Hematopoietic reconstitution after autologous blood stem cell transplantation
11. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
12. High CD34 cell counts decrease hematologic toxicity of amologous peripheral blood progenitor cell transplantation
13. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines
14. Enumeration of CD34+ hematopoietic stem and progenitor cells
15. The ISHAGE guidelines for CD34+ cell determination by flow cytometry
16. Factors that influence collection and engraftment of autologous peripheral-blood stem cells
17. Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients
18. A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts
19. Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells
20. Peripheral blood stem cell quantitation
21. Damage and protection of UC blood cells during cryopreservation
22. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion
23. Filgastrim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy
24. Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: Effects of storage media, temperature and time
25. Factors influencing mobilization and engraftment in patients with metastatic breast cancer undergoing PBSC transplantation
26. Enumeration of CD34+ cells in cord blood: A variation on a single-platform flow cytometric method based on the ISHAGE gating strategy